Unsolicited/”hostile” bids comprise an increasingly significant portion of M&A volume. To minimize the risk of its company becoming the target of a successful hostile bid, a board of directors must put in place preventive measures that will allow the company to prepare for and defend against hostile activity was the main focus of this panel. The board always must keep in mind that a hostile bid presents a serious risk that control of the company will change and that being unprepared significantly increases that risk.
Related Insights
02 June 2025
Events
Biotech Panel Discussion & Happy Hour
Join Foley & Lardner LLP along with Biotech XYZ for an engaging evening event featuring a dynamic panel discussion and a lively happy hour.
03 June 2025
Events
Biotech Breakfast + Office Hours
Join Foley & Lardner LLP along with Biotech XYZ for Phase Capitals’ flagship networking biotech breakfast and office hours with Q&A sessions.
30 June 2025
Events
AHLA Annual Meeting
Foley partners Judy Waltz, chair of the firm’s Health Care Practice Group, and Leah D'Aurora Richardson are speaking in the American Health Law Association’s (AHLA) Annual Meeting in San Diego, CA. Waltz is hosting the session “Evolving Expectations: Medicare Advantage Compliance for Plans and Providers,” and Richardson is speaking in the session “Getting Aligned: Structuring Strategic Affiliations for Community Providers.”